High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk

van der Steeg, Wim A., Holme, Ingar, Boekholdt, S. Matthijs, Larsen, Mogens Lytken, Lindahl, Christina, Stroes, Erik S.G., Tikkanen, Matti J., Wareham, Nicholas J., Faergeman, Ole, Olsson, Anders G., Pedersen, Terje R., Khaw, Kay-Tee, Kastelein, John J.P.·2008·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2007.09.060

Cited by (374)

Items 301–374 of 374

  1. Attainment of combined optimal lipid values: a paradigm shift in the management of dyslipidemia
    Mark J. Cziraky, Tyan F. Thomas · 2010 · Clinical Lipidology
  2. Non-invasive measurement of cholesterol in human blood by impedance technique: an investigation by 2D finite element field modelling
    Ekaterina Aristovich, Sanowar H. Khan · 2013 · Journal of Physics Conference Series
  3. Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development
    MyNgan Duong, Stephen James Nicholls · 2009 · Expert Opinion on Drug Discovery
  4. The Failure of Vytorin and Statins to Improve Cardiovascular Health: Bad Cholesterol or Bad Theory?
    Brian Scott Peskin, David Sim, Marissa Janine Carter · 2008
  5. Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction
    Marica Cariello, Roberto Salvia, Jennifer Härdfeldt, Marilidia Piglionica, David Rutigliano, Pasquale Caldarola, Alice Ossoli, Michèle Vacca, Giusi Graziano, Stefano Battaglia et al. · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  6. High-density lipoprotein metrics during midlife and future subclinical atherosclerosis in women: the SWAN HDL study
    Alexis Nasr, Maria M. Brooks, Emma Barinas‐Mitchell, Trevor John Orchard, Jeffrey T. Billheimer, Norman C. Wang, Daniel S McConnell, Daniel James Rader, Samar R. El Khoudary · 2024 · Menopause The Journal of The North American Menopause Society
  7. High-Density Lipoprotein and High-Density Lipoprotein Cholesterol
    Kayla A. Riggs, Anand K. Rohatgi · 2018 · Elsevier eBooks
  8. The case against ApoB and the ApoB:ApoA-I ratio: are they right?
    Allan D. Sniderman · 2008 · Future Lipidology
  9. DEFINING THE AFRICAN GREEN MONKEY (CHLOROCEBUS AETHIOPS): EXPRESSION BEHAVIOUR OF SELECTED LIPID METABOLISM GENES IN RESPONSE TO NIACIN
    Chesa Gift Chauke · 2012 · UWC Research Repository (University of the Western Cape)
  10. The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
    آقاسی زاده, ملیحه, غیور مبرهن, مجید, کاظمی, طوبی, آوان, امیر, میری مقدم, ابراهیم · 2020 · مجله علمی دانشگاه علوم پزشکی بیرجند
  11. Risk Factors for COVID-19 Infection in Adult Patients: A Retrospective Observational Study in Japan
    Akie Yoshida, Kazuhiro Furumachi, Etsuko Kumagai, Keiko Hosohata · 2024 · Infection and Drug Resistance
  12. Nutritional Aspects of Fats and Oils
    Bente Kirkhus, Gudrún V. Skúladóttir, Anna‐Maija Lampi, Astrid Nilsson · 2024 · Springer eBooks
  13. High-density lipoprotein cholesterol, particles and subspecies and the risk of chronic kidney disease: The PREVEND prospective study
    Setor Kwadzo Kunutsor, Margery A. Connelly, Stephan J. L. Bakker, Robin P. F. Dullaart · 2025 · Lipids in Health and Disease
  14. Early cardiometabolic dysfunction: subclinical indicators and sex-specific considerations
    Casey G. Turner, Nina Lawrene Stute, Devin K. S. Parker, L. Bruce Gladden, Michael D. Roberts · 2026 · American Journal of Physiology-Heart and Circulatory Physiology
  15. Advanced Lipid Testing
    Matthew J. Sorrentino · 2011 · Humana Press eBooks
  16. Dusty Punch Cards and an Eternal Enigma: High-Density Lipoproteins and Atherosclerosis
    Marcus Edi Kleber, Tanja B. Grammer, Ursula Kassner, Günther Silbernagel, Winfried März · 2014 · Drugs
  17. What intervention trials don’t tell us: the residual risk in primary prevention
    Claudio Cimminiello · 2011 · Internal and Emergency Medicine
  18. Effects of Salt Intake on Blood Pressure in Banovici Coal Mine Workers
    Munevera Bećarević, Nizama Salihefendić, Muharem Zildžić · 2014 · Materia Socio Medica
  19. Cardiovascular Risk Reduction via Increasing HDL Cholesterol: The Promise of the dal-OUTCOMES Trial
    Kyaw Khaing Soe, Anis Alam, Charles Philip, Edison Ruiz, Keshwar Ramkissoon, Samy I. McFarlane · 2010 · Current Diabetes Reports
  20. Highlights of the Year in JACC 2008
    Anthony Nicholas DeMaria, Ori Ben‐Yehuda, Jeroen Joost Bax, Gregory K. Feld, Barry Greenberg, Wilbur Y.W. Lew, João A.C. Lima, Alan S. Maisel, Sanjiv M. Narayan, David J. Sahn et al. · 2009 · Journal of the American College of Cardiology
  21. Changes in the Lipid Profile of Patients with Acute Coronary Syndromes within the First Days of Hospitalization
    Daniel Alberto Siniawski, Walter M. Masson, J.L. Navarro, Mauro L. Giacomini, Guillermo Jaimovich, F. J. Parcerisa, Luciano De Stefano, Patricia Beatriz Sorroche, Liliana Casañas, Juan G. Krauss et al. · 2010
  22. Cholesterol HDL — friend or foe?
    Joanna Banach, Włądysław Sinkiewicz · 2013 · Kardiologia Polska
  23. Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction (STEMI).
    Aleksander Siniarski · 2018 · The Anatolian Journal of Cardiology
  24. Vitamin E, high-density lipoproteins, and vascular protection in diabetes
    Tina Costacou, Joshua B. Wiener, Elliot M. Berinstein, Andrew P. Levy · 2020 · Elsevier eBooks
  25. Lipids, atherosclerosis, and microvascular disease: Translating basic science into pharmacotherapeutics
    Bilal Bashir, Zohaib Iqbal, Jonathan D. Schofield, Handrean Soran · 2023 · Elsevier eBooks
  26. Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses
    Junko Yachida, Kazuya Fujihara, Mayuko Harada Yamada, Ayako Kobayashi, LAY MON KHIN, HIROKI TAKIZAWA, Masahiko Yamamoto, Masaru Kitazawa, Yasuhiro Matsubayashi, Takaho Yamada et al. · 2024 · Diabetes Obesity and Metabolism
  27. Emerging High-Density Lipoprotein-Targeted Therapies: Cholesteryl Ester Transfer Protein Inhibitors, Apolipoprotein A-I Mimetics
    Ritu Bhatia, Vansh Dhawan, Ansh Bhatia, Ruchi Gupta, Mamtesh Gupta · 2025 · Indian Journal of Cardiovascular Disease in Women
  28. Therapies Targeting HDLc Levels and HDL Function
    Cecilia Vitali, Marina Cuchel · 2017 · Elsevier eBooks
  29. Lipid Measurements
    Anand K. Rohatgi · 2017 · Elsevier eBooks
  30. [Major influence of dysfunctions of protective serum proteins on cardiometabolic risk among Turks and gender difference].
    Altan Onat, Gülay Hergenç, Günay Can · 2009 · PubMed
  31. [Egg consumption and cardiovascular health].
    Meral Kayıkçıoğlu, İnan Soydan · 2009 · PubMed
  32. Therapeutic Regulation of High-Density Lipoprotein Transport in the Metabolic Syndrome
    Dick C. Chan, P. Hugh R. Barrett, Gerald Francis Watts · 2010 · Springer eBooks
  33. CHALLENGES IN ATHEROSCLEROSIS
    John S. Millar · 2011 · Cambridge University Press eBooks
  34. Anti‐Unicorn Principle: Appropriate Biomarkers Don't Need to be Rare or Hard to Find
    Michael R. Bleavins, Ramin Rahbari · 2010 · Pharmaceutical Sciences Encyclopedia
  35. Enhancement of HDL Formation and Normalization of Intravascular HDL Remodeling
    Anatol Kontush, M. John Chapman · 2011 · Wiley eBooks
  36. Variación del perfil lipídico durante los primeros días de la internación en pacientes con síndrome coronario agudo
    Daniel Alberto Siniawski, Walter M. Masson, Jose Luis Navarro Estrada, Mauro L. Giacomini, Guillermo Jaimovich, Florencia Parcerisa, Luciano De Stefano, Patricia Beatriz Sorroche, Liliana Casañas, Juan G. Krauss et al. · 2025 · Revista Argentina de Cardiología
  37. Severe HDL-c reduction during rosiglitazone therapy in an obese woman with type 2 diabetes
    Ricardo Luiz de Almeida, Paulo Fedrizzi, Daniela Fedrizzi, Tobias Skrebsky de Almeida · 2010 · Arquivos Brasileiros de Endocrinologia & Metabologia
  38. Intracoronary IVUS for Evaluation of Atherosclerosis Progression
    Kiyoko Uno, Yu Kataoka, Rishi Puri, Stephen James Nicholls · 2012 · Current Cardiovascular Imaging Reports
  39. Visceral Adipose Tissue: At the Intersection of Lipoprotein Associated CV Risk
    Robert S. Rosenson · 2013 · Global Heart
  40. Dissecting lipid and lipoprotein issues in women: anin utero-through-menopause journey
    Thomas D. Dayspring, Seth J. Baum · 2015 · Clinical Lipidology
  41. Research Article Kynamro (Mipomersen): A Cholesterol Reducing Drug
    Dilipkumar Pal, Tanmoy De, Arijit Baral, Arvind Kumar · 2013
  42. Niveles séricos de Apolipoproteínas A-I y B en niños escolares de escuelas rurales Serum Levels of Apolipoprotein A-I and B in Rural Schoolchildren
    Liliana Jenny, Jorge Zenteno, Valentina Díaz, Irene Ruíz, Javier Zárate · 2011
  43. Altos Níveis de HDL Colesterol: Proteção ou Risco Cardiovascular? Relato de Caso High Levels of HDL Cholesterol: Protection or Cardiovascular Risk? Case Report
    Rodrigo Toshiharu Fujisawa, Alexandre Eduardo, Franzin Vieira, Renato Massashi Fujisawa · 2008
  44. GENETIC CHARACTERIZATION OF THE ST. KITTS-ORIGIN VERVET MONKEY (CHLOROCEBUS AETHIOPS SSP.) AS A MODEL OF POLYGENIC OBESITY
    Stanton B. Gray · 2009 · WakeSpace Scholarship (Wake Forest University)
  45. Cholesterol HDL — przyjaciel czy wróg? Cholesterol HDL — friend or foe?*
    Joanna Banach, Bydgoszcz · 2013
  46. Which should be the goals of apolipoprotein A1? Analysis of a healthy population in Argentina
    Walter M. Masson, Daniel Alberto Siniawski, Patricia Beatriz Sorroche, Walter Scordo · 2012 · Revista Argentina de Cardiología
  47. The Mystery of High-density Lipoprotein: Quantity or Quality? Update on Therapeutic Strategies.
    Vasiliki K. Katsi, Manolis S. Kallistratos, Antonios N. Pavlidis, Nikos Karpettas, Ioannis Skoumas, Nikonas Pavleros, Athanasios John Manolis, Christos S. Pitsavos, Dimitris Tousoulis, Christodoulos Stefanadis et al. · 2015 · PubMed
  48. Interventions in the metabolic syndrome: bile acid sequestration and exercise
    Maxi Meissner · 2010 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  49. Lipoprotein Subclass Measurements by an Updated Nuclear Magnetic Resonance Spectroscopy Method in the Prediction of Coronary Artery Disease in Type 1 Diabetes
    Qing Xu · 2014
  50. Three Finite Vascular Responses that Cause Coronary Heart Disease and Cardiovascular Disease: Implications for Diagnosis and Treatment
    Mark C. Houston · 2019 · Alternative and Complementary Therapies
  51. Revolutionary New Concepts in the Prevention and Treatment of Cardiovascular Disease
    Mark C. Houston · 2020 · Springer eBooks
  52. Effect of a Lifestyle and Type 2 Diabetes-Prevention Intervention on Biomarkers of Oxidative Stress in Obese Prediabetic Latino Youth
    Renteria Mexia, Ana María · 2017
  53. Biologie Vasculaire
    2010 · Elsevier eBooks
  54. Anti‐Unicorn Principle
    Michael R. Bleavins, Ramin Rahbari · 2020
  55. Case report: 68 yo Chinese-American woman with high HDL-C and ischemic stroke attributed to intracranial atherosclerotic stenosis
    Jan Gong, Stephanie Byers Asher, Brett L. Cucchiara, Marina Cuchel, Daniel E. Soffer · 2021 · Journal of clinical lipidology
  56. Aktueller Stellenwert der HDL-Cholesterin-Bestimmung für die kardiovaskuläre Risikoabschätzung
    Wijtske Annema · 2021 · Praxis
  57. "The higher the better" seems to be no longer true for HDL-cholesterol
    Hana Rosolová · 2018 · Vnitřní lékařství
  58. Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados
    Albert Teis, Esmeralda Castelblanco, Germán Cediel, Núria Amigó, Josep Julve, Josep Ribalta, Montse Guardiola, Josep Franch‐Nadal, Marcelino Bermúdez-López, Pau Codina et al. · 2022 · Revista Española de Cardiología
  59. Epidemiology
    Anatol Kontush, M. John Chapman · 2011 · Wiley eBooks
  60. Current World Literature
    2008 · Current Opinion in Lipidology
  61. Current World Literature
    2009 · Current Opinion in Endocrinology Diabetes and Obesity
  62. The Role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
    آقاسی زاده, ملیحه, غیور مبرهن, مجید, کاظمی, طوبی, آوان, امیر, میری مقدم, ابراهیم · 2020 · مجله علمی دانشگاه علوم پزشکی بیرجند
  63. Transfer Proteins, Lipoprotein Remodeling, and Antioxidant Action on Pregnant Women: Comparison from the First to the Third Trimester of Gestation
    Ana Paula Caires dos Santos, Adriano Costa de Alcântara, Milena Botelho Pereira Soares, Débora F. Deus, Fatima Rodrigues Freitas, Fábio David Couto, Nadielle Silva Bidu, Daniele Brustolim, Raul Cavalcante Maranhão, Ricardo David Couto · 2023 · The Open Biomarkers Journal
  64. Labordiagnostik von Fettstoffwechselstörungen
    Winfried März, Hubert Scharnagl, Marcus Edi Kleber, Günther Silbernagel, Matthias Nauck, Dirk Müller‐Wieland, Arnold von Eckardstein · 2024 · Diabetes aktuell
  65. Additional file 1 of Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials
    Yang, Chao, Xia, Hui, Wan, Min, Lu, Yifei, Xu, Dengfeng, Xian Yang, Yang, Ligang, Sun, Guiju · 2021 · Figshare
  66. Additional file 6 of Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials
    Yang, Chao, Xia, Hui, Wan, Min, Lu, Yifei, Xu, Dengfeng, Xian Yang, Yang, Ligang, Sun, Guiju · 2021 · Figshare
  67. Additional file 2 of Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials
    Yang, Chao, Xia, Hui, Wan, Min, Lu, Yifei, Xu, Dengfeng, Xian Yang, Yang, Ligang, Sun, Guiju · 2021 · Figshare
  68. Additional file 4 of Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials
    Yang, Chao, Xia, Hui, Wan, Min, Lu, Yifei, Xu, Dengfeng, Xian Yang, Yang, Ligang, Sun, Guiju · 2021 · Figshare
  69. Additional file 5 of Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials
    Yang, Chao, Xia, Hui, Wan, Min, Lu, Yifei, Xu, Dengfeng, Xian Yang, Yang, Ligang, Sun, Guiju · 2021 · Figshare
  70. Additional file 3 of Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials
    Yang, Chao, Xia, Hui, Wan, Min, Lu, Yifei, Xu, Dengfeng, Xian Yang, Yang, Ligang, Guiju Sun · 2021 · Figshare
  71. Additional file 1 of Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)
    Arno R. Bourgonje, Margery A. Connelly, Harry van Goor, van Dijk, Peter R., Robin P. F. Dullaart · 2024 · Figshare
  72. Dissecting the Genetic Link Between Insulin Resistance and Coronary Heart Disease: A Multi-Trait GWAS and Proteomic-Metabolomic Mediation Analysis
    Rui Dong, Jiao Fu, Bowen Zhang, Qingling Zhang, Yang Yan, Guoliang Li · 2026 · medRxiv
  73. Mechanism-based biomarkers for early detection and plaque vulnerability assessment in atherosclerosis
    Diksha Choudhary, Samriddhi Bali, Shubhdeep Singh Bandral, Varinder Singh, Md Altamash Ahmad, Balakumar Chandrasekaran, Rajwinder Kaur · 2026 · Biochemical and Biophysical Research Communications
  74. Lipids in endothelial-to-mesenchymal transition
    Christina K. Tripsas, Abigail Y. Tsai, Jeffrey J. Hsu · 2026 · Current Opinion in Lipidology